Lower plasma protein C activity is associated with early myocardial necrosis and no-reflow phenomenon in patients with ST elevation myocardial infarction

Acta Cardiol. 2019 Aug;74(4):331-339. doi: 10.1080/00015385.2018.1494116. Epub 2018 Sep 11.

Abstract

Background: Activity of protein C has important role in the development of early necrosis and no-reflow phenomenon in patients with ST-segment elevation myocardial infarction (STEMI) after successful primary percutaneous coronary intervention (pPCI). Methods: We examined association between plasma activity of protein C, antithrombin, coagulation factors II, VII, VIII and fibrinogen to early formation of new Q-waves (myocardial necrosis) before pPCI and early ST-segment resolution (microcirculatory reperfusion) after pPCI in patients with acute STEMI. According to ischaemic time, patients were considered as early or late presenters. 12-lead ECG was analysed for the presence of new Q-wave at admission and for significant ST-segment resolution 60 minutes after primary PCI. Results: In early presenters' group, protein C activity was significantly lower in patients who did not achieve significant ST-segment resolution after pPCI compared to patients who did (1.11 IU/L vs. 0.99 IU/L, p = .006) and in patients who had new Q-waves compared to group who had not (1.04 UI/l vs. 1.11 IU/L, p = .038). There was significant negative correlation between protein C activity and maximal CK-MB levels (R2 = 0.06, p = .009) and BNP levels (R2 = 0.109, p = .003) and significant positive correlation between protein C activity with LVEF (R2 = 0.065, constant = 33.940, b = 11.968, p = .007) in early STEMI presenters. There were no differences between the activity of other examined haemostasis factors. Conclusion: Therefore we concluded that STEMI patients with early myocardial necrosis and no-reflow phenomenon after pPCI have lower activity of plasma protein C levels.

Keywords: Protein C activity; ST elevation myocardial infarction; early myocardial necrosis; no-reflow phenomenon.

MeSH terms

  • Aged
  • Biomarkers / blood
  • Down-Regulation
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardium / pathology*
  • Necrosis
  • No-Reflow Phenomenon / diagnostic imaging
  • No-Reflow Phenomenon / etiology*
  • No-Reflow Phenomenon / physiopathology
  • Percutaneous Coronary Intervention / adverse effects*
  • Prospective Studies
  • Protein C / analysis*
  • Risk Factors
  • ST Elevation Myocardial Infarction / blood
  • ST Elevation Myocardial Infarction / diagnostic imaging
  • ST Elevation Myocardial Infarction / therapy*
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • Protein C